At a Glance
- Triton Acquisition of Clinigen 05 Apr 2022
- Half year results for the six months ended 31 December 2021 23 Feb 2022
- Clinigen and Deciphera Sign Distribution Agreement 09 Feb 2022
Latest resultsHalf year results for the six months ended 31 December 2021
23 Feb 2022
Shaun Chilton, Group CEO
"COVID-19 had a continued impact on our markets leading to a decline in EBITDA compared to prior year.
The business continues to meet challenges head on with a significant number of business wins across both the Services and Products divisions, and the roll-out of key products Erwinase and Hunterase."
Annual Report 2021
Download the latest Annual Report and Accounts 2021.